Loading...
Mixed Asset Passive

KBSTAR Healthcare Fixed Income Balanced (253290)

Update : 2024.02.21

NAV

11,634KRW

+10.53상승 (0.09%)

Market Price per share (KRW)

11,640KRW

+15상승 (0.13%)

※ t-1 last price

trading volume

14,504shares

AUM

KRW 13.9billion

KBSTAR Healthcare Fixed Income Balanced (253290)

KEY POINT

Balanced ETF with both the stability of bonds and the profitability of stocks

KEY POINT

Seek to achieve stable yield of bonds and the profitability of the healthcare sector

Basic information

Download trading information

Update : 2024.02.21
ETF name(Code), Benchmark Index, Inception date, creation unit, Net Asset (KRW 0.1 billion), Trustee, Rule of Dividend payment, Market Price per share (KRW), iNAV per share (KRW), trading volume (share), Total Expense ratio table
ETF Name (code) Benchmark Index Inception date Creation Unit AUM (KRW)
KB KBSTAR HealthCare FixedIncome Balanced ETF
(253290)
FnGuide HealthCare Mix Index 2016.09.23 200,000 13,960,734,004
Trustee Market Price per share (KRW) NAV Trading Volume (shares)
하나은행 11,640
※ t-1 last price
11,633 14,504
authorized participant, Liquidity provider table
Total Expense Ratio Distribution Frequency 다운로드 버튼
Year 0.35% (Designated participating company : 0.03%, Collective investment : 0.28%, trust : 0.02%, General affairs : 0.02%) Based on the business day before the interest payment date of the stocks constituting the index in June and December (occasional payment)
Authorized Participants Liquidity Providers
KB Securities, NH Investment & Securities, Meritz Securities, Samsung Securities KB Securities, NH Investment & Securities, Samsung Securities
ETF name(Code), Benchmark Index, Inception date, creation unit, AUM(0.1 billion) (KRW), Trustee, Rule of Dividend payment, Market Price per share (KRW), iNAV per share (KRW), trading volume (share), Total Expense ratio table
ETF Name(Code) Benchmark Index
KB KBSTAR HealthCare FixedIncome Balanced ETF

(253290)
FnGuide HealthCare Mix Index
Inception date Creation Unit
2016.09.23 200,000
AUM(0.1 billion) (KRW) Trustee
13,960,734,004 하나은행
Market Price per share (KRW) iNAV per share (KRW)
11,640
※ t-1 last price
11,633
Trading Volume (shares)
14,504
authorized participant, Liquidity provider table
Total Expense Ratio
Year 0.35% (Designated participating company : 0.03%, Collective investment : 0.28%, trust : 0.02%, General affairs : 0.02%)
Distribution Frequency
Based on the business day before the interest payment date of the stocks constituting the index in June and December (occasional payment)
Authorized Participants
KB Securities, NH Investment & Securities, Meritz Securities, Samsung Securities
Liquidity Providers
KB Securities, NH Investment & Securities, Samsung Securities

Index Introduction

The FnGuide Healthcare Balanced Index is an index consisting of stock items constituting the FnGuide Healthcare Index and three KTBs constituting the MKF 3-year KTB Index. It maintains a 7:3 ratio of bonds to stocks everyday.

View detailed index information

TOP 10 Holdings

Update : 2024-02-21
Rank , Name, proportion table
Rank Name Weight (%)
1 KTB04250-2512(22-13) 21.97
2 KTB03125-2606(23-4) 17.90
3 KTB03500-2809(23-6) 14.58
4 KBSTAR HealthCare 11.96
5 F 202403 9.20
6 원화예금 8.43
7 HLB 3.78
8 KTB01875-2412(21-10) 3.55
9 SAMSUNG BIOLOGICS 2.25
10 Celltrion 1.89

proportion by sectors

*The proportion of investment stocks

Update : 2024.02.21
Rank , Name, proportion table
Rank Name Weight (%)
1 Healthcare 100.00

Dividend payment data

· Payable date of dividend payment 3 years.
Rule of Dividend payment, Payable date of dividend payment, dividend per share (KRW) table
Rule of Dividend payment Payable date of dividend payment dividend per share (KRW)
2023-12-08 2023-12-12 110
2023-06-08 2023-06-12 40
2022-12-08 2022-12-12 91
2022-06-09 2022-06-13 16
2021-12-09 2021-12-13 11
2021-06-09 2021-06-11 10

Performance

performance

excel download

Update : 2024-02-21

 (as of Oct : %)

The result of above Net Asset Value performance is the rate of return assuming distribution reinvestment.

classification, 1Month, 3Month, 6Month, 1year, 3year, YTD (Year to date), Since inception, NAV, Benchmark Index, Outperformance table
classification 1Month 3Month 6Month 1year 3year YTD
(Year to date)
Since
inception
NAV 3.32 6.42 6.98 9.25 -5.28 0.43 19.36
Benchmark Index 3.14 6.34 7.23 10.28 -3.42 0.44 23.74
Outperformance 0.17 0.08 -0.25 -1.03 -1.87 -0.02 -4.38

daily Performance

excel download

date, market price (KRW), NAV (KRW)
date Market price (KRW) NAV (KRW)
closing price Daily Return(%) closing price Daily Return(%)
2024.02.20 11,640 0.129상승 11,633.95 0.090상승
2024.02.19 11,625 0.823상승 11,623.42 0.792상승
2024.02.16 11,530 0.304상승 11,530.93 0.285상승
2024.02.15 11,495 -0.303하락 11,498.13 -0.293하락
2024.02.14 11,530 -0.689하락 11,531.96 -0.622하락
2024.02.13 11,610 0.912상승 11,604.24 0.694상승
2024.02.08 11,505 -0.260하락 11,522.14 -0.229하락
2024.02.07 11,535 0.086상승 11,548.64 0.027상승
2024.02.06 11,525 0.435상승 11,545.51 0.489상승
2024.02.05 11,475 -0.477하락 11,489.32 -0.408하락
2024.02.02 11,530 0.963상승 11,535.43 0.947상승
2024.02.01 11,420 -0.522하락 11,427.14 -0.406하락
2024.01.31 11,480 -0.433하락 11,473.82 -0.540하락
2024.01.30 11,530 0.566상승 11,536.21 0.633상승
2024.01.29 11,465 -0.130하락 11,463.61 -0.130하락
2024.01.26 11,480 1.056상승 11,477.57 0.993상승
2024.01.25 11,360 0.442상승 11,364.64 0.409상승
2024.01.24 11,310 -0.527하락 11,318.3 -0.503하락
2024.01.23 11,370 0.264상승 11,375.53 0.380상승
2024.01.22 11,340 0.576상승 11,332.37 0.633상승

Holdings

Name, Ticker, Number. of shares, Weight(%), market price (KRW)
No. (Number) Name Ticker Number of shares
/ Par value
Weight(%) Market price (KRW)
1 KTB04250-2512(22-13) KR103501GCC0 500,000,000 21.97 511,124,000
2 KTB03125-2606(23-4) KR103501GD65 416,666,667 17.9 416,492,916
3 KTB03500-2809(23-6) KR103501GD99 333,333,333 14.58 339,137,332
4 KBSTAR HealthCare KR7253280002 21,141 11.96 278,215,560
5 F 202403 KR4165V30000 2.05 9.2 214,102,000
6 원화예금 KRD010010001 196,124,381 8.43 196,124,381
7 HLB KR7028300002 1,109 3.78 88,054,600
8 KTB01875-2412(21-10) KR103501GBC2 83,333,333 3.55 82,584,416
9 SAMSUNG BIOLOGICS KR7207940008 64 2.25 52,352,000
10 Celltrion KR7068270008 245 1.89 44,075,500
11 Yuhan KR7000100008 583 1.63 37,953,300
12 HanmiPharm KR7128940004 80 1.18 27,360,000
13 SKBP KR7326030004 283 1.08 25,187,000
14 Celltrionph KR7068760008 200 0.87 20,340,000
15 SKBS KR7302440003 221 0.62 14,365,000
16 HANALL BIOPHARMA KR7009420001 367 0.56 12,973,450
17 Hanmi Science KR7008930000 283 0.52 12,041,650
18 MedyTox KR7086900008 57 0.46 10,687,500
19 SCD KR7000250001 145 0.43 9,889,000
20 CHONGKUNDANG KR7185750007 86 0.41 9,606,200
21 SEEGENE KR7096530001 334 0.37 8,667,300
22 DENTIUM KR7145720009 68 0.33 7,656,800
23 CHA Biotech KR7085660009 414 0.32 7,501,680
24 GC Corp KR7006280002 57 0.29 6,708,900
25 ST Pharm KR7237690003 104 0.28 6,541,600
26 BIONEER KR7064550007 231 0.26 6,109,950
27 HK inno.N KR7195940002 148 0.25 5,897,800
28 PharmaResearch KR7214450009 64 0.25 5,856,000
29 CLASSYS KR7214150005 179 0.24 5,665,350
30 DAEWOONG PHARM KR7069620003 47 0.24 5,593,000
31 HLBPHARMA KR7047920004 266 0.22 5,152,420
32 JWPHARMA KR7001060003 139 0.22 5,045,700
33 Daewoong KR7003090008 204 0.21 4,855,200
34 i-SENS KR7099190001 217 0.21 4,828,250
35 SD Biosensor KR7137310009 371 0.21 4,804,450
36 ShinpoongPharm KR7019170000 344 0.2 4,558,000
37 Jeisys Medical KR7287410005 554 0.2 4,758,860
38 DongKook Pharm KR7086450004 241 0.19 4,446,450
39 WONTECH KR7336570007 441 0.17 3,969,000
40 Donga ST KR7170900005 52 0.16 3,728,400
41 Boryung KR7003850005 307 0.16 3,806,800
42 GC CELL KR7144510005 82 0.14 3,189,800
43 Amicogen KR7092040005 466 0.13 2,921,820
44 INTEROJO KR7119610004 84 0.12 2,713,200
45 ILDONG PHARM KR7249420001 174 0.12 2,796,180
46 Huons KR7243070000 69 0.11 2,556,450
47 KwangdongPharm KR7009290008 329 0.11 2,562,910
48 HUMASIS KR7205470008 1,170 0.09 2,141,100
49 Ray KR7228670006 116 0.08 1,967,360
50 Aprogen KR7007460009 1,353 0.05 1,224,465
Investment notice
- The information provided on this website is based on reliable sources, but its accuracy and completeness are not guaranteed.
- Financial investment products are not protected by the Korea Deposit Insurance Corporation in accordance with the Depositor Protection Act, and a loss of investment principal may occur, which belongs to the investor.
- Past performance does not guarantee future profits.
- In the case of a collective investment scheme that invests in foreign securities, asset values may be lost due to risks caused by market, political, and economic conditions in the target country.
- Derivatives may lose all or a significant portion of the investment principal in a short period of time due to high price volatility, and there is a risk that the counterparty may not be able to fulfill the terms of the contract when investing in over-the-counter derivatives.
- Before investing, be sure to read the investment prospectus and contract recommendation document regarding the investment subject, redemption method, and fee.